المؤلفون: Bejanyan, N, Zhang, MJ, Bo-Subait, K, Brunstein, C, Wang, HL, Warlick, ED, Giralt, S, Nishihori, T, Martino, R, Passweg, J, Dias, A, Copelan, E, Hale, G, Gale, RP, Solh, M, Kharfan-Dabaja, MA, Diaz, MA, Ganguly, S, Gore, S, Verdonck, LF, Hossain, NM, Kekre, N, Savani, B, Byrne, M, Kanakry, C, Cairo, MS, Ciurea, S, Schouten, HC, Bredeson, C, Munker, R, Lazarus, H, Cahn, JY, van der Poel, M, Rizzieri, D, Yared, JA, Freytes, C, Cerny, J, Aljurf, M, Palmisiano, ND, Pawarode, A, Bacher, VU, Grunwald, MR, Nathan, S, Wirk, B, Hildebrandt, GC, Seo, S, Olsson, RF, George, B, de Lima, M, Hourigan, CS, Sandmaier, BM, Litzow, M, Kebriaei, P, Saber, W, Weisdorf, D

المصدر: Transplantation and cellular therapy. 27(1)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:146049185

المؤلفون: Manobianco SA; Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States., Rakiewicz T; Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States., Wilde L; Department of Medical Oncology, Division of Hematologic Malignancy and Stem Cell Transplantation, Philadelphia, PA, United States., Palmisiano ND; Department of Medical Oncology, Division of Hematologic Malignancy and Stem Cell Transplantation, Philadelphia, PA, United States.

المصدر: Frontiers in oncology [Front Oncol] 2022 Jul 12; Vol. 12, pp. 892289. Date of Electronic Publication: 2022 Jul 12 (Print Publication: 2022).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Keiffer G; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States., Aderhold KL; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States., Palmisiano ND; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States.

المصدر: Frontiers in oncology [Front Oncol] 2020 Dec 22; Vol. 10, pp. 562219. Date of Electronic Publication: 2020 Dec 22 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Diefenbach CS; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA. Electronic address: catherine.diefenbach@nyulangone.org., Hong F; Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Biostatistics Center, Dana Farber Cancer Institute, Boston, MA, USA., Ambinder RF; Department of Oncology, Johns Hopkins University, Baltimore, MD, USA., Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Robertson MJ; School of Medicine, Indiana University, Bloomington, IN, USA., David KA; Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Jersey, NJ, USA., Advani RH; Oncology Division, Stanford Cancer Institute, Stanford, CA, USA., Fenske TS; Division of Hematology and Oncology, Froedtert and the Medical College of Wisconsin, Wauwatosa, WI, USA., Barta SK; Divison of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Palmisiano ND; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Svoboda J; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Morgan DS; Vanderbilt University Medical Center, Nashville, TN, USA., Karmali R; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, USA., Sharon E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethseda, MD, USA., Streicher H; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethseda, MD, USA., Kahl BS; School of Medicine, Washington University, St Louis, MO, USA., Ansell SM; Division of Hematology, Mayo Clinic, Rochester MN, USA.

المصدر: The Lancet. Haematology [Lancet Haematol] 2020 Sep; Vol. 7 (9), pp. e660-e670.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Brentuximab Vedotin/*therapeutic use , Hodgkin Disease/*drug therapy , Ipilimumab/*therapeutic use , Nivolumab/*therapeutic use, Adult ; Aged ; Antineoplastic Agents, Immunological/adverse effects ; Brentuximab Vedotin/adverse effects ; Disease Progression ; Drug Therapy, Combination ; Female ; Hodgkin Disease/mortality ; Hodgkin Disease/pathology ; Humans ; Hypersensitivity/etiology ; Ipilimumab/adverse effects ; Male ; Middle Aged ; Nivolumab/adverse effects ; Pain/etiology ; Progression-Free Survival ; Recurrence ; Survival Rate ; Treatment Outcome

المؤلفون: Zhu L; Institute of Infectious Diseases, Beijing Ditan Hospital, Beijing Key Laboratory of Emerging Infectious Diseases, Capital Medical University, Beijing, China.; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA., Kong Y; Institute of Infectious Diseases, Beijing Ditan Hospital, Beijing Key Laboratory of Emerging Infectious Diseases, Capital Medical University, Beijing, China.; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA., Zhang J; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA., Claxton DF; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA., Ehmann WC; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA., Rybka WB; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA., Palmisiano ND; Depatment of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA., Wang M; Department of Public Health Sciences, Penn State University College of Medicine, Hershey, PA, USA., Jia B; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA., Bayerl M; Department of Pathology, Penn State Hershey Medical Center, Penn State University College of Medicine, Hershey, PA, 17033, United States., Schell TD; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA.; Department of Microbiology and Immunology, Penn State University College of Medicine, Hershey, PA, USA., Hohl RJ; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA., Zeng H; Institute of Infectious Diseases, Beijing Ditan Hospital, Beijing Key Laboratory of Emerging Infectious Diseases, Capital Medical University, Beijing, China. zenghui@ccmu.edu.cn., Zheng H; Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA, USA. hzheng@pennstatehealth.psu.edu.; Department of Microbiology and Immunology, Penn State University College of Medicine, Hershey, PA, USA. hzheng@pennstatehealth.psu.edu.

المصدر: Journal of hematology & oncology [J Hematol Oncol] 2017 Jun 19; Vol. 10 (1), pp. 124. Date of Electronic Publication: 2017 Jun 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Regulation, Leukemic*, Leukemia, Myeloid, Acute/*genetics , Leukemia, Myeloid, Acute/*pathology , Positive Regulatory Domain I-Binding Factor 1/*immunology , Programmed Cell Death 1 Receptor/*genetics , Receptors, Immunologic/*genetics , T-Lymphocytes/*pathology, Adult ; Aged ; Cytokines/immunology ; Female ; Humans ; Leukemia, Myeloid, Acute/immunology ; Male ; Middle Aged ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Transcriptional Activation ; Up-Regulation ; Young Adult

المؤلفون: Palmisiano ND; Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania., Kasner MT; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.

المصدر: American journal of hematology [Am J Hematol] 2015 Nov; Vol. 90 (11), pp. 1071-6. Date of Electronic Publication: 2015 Oct 08.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Cell Cycle Proteins/*antagonists & inhibitors , Hematologic Neoplasms/*drug therapy , Hematologic Neoplasms/*genetics , Protein Kinase Inhibitors/*therapeutic use , Protein Serine-Threonine Kinases/*antagonists & inhibitors , Proto-Oncogene Proteins/*antagonists & inhibitors, Animals ; Cell Cycle/drug effects ; Cell Cycle/genetics ; Cell Cycle Proteins/genetics ; Clinical Trials as Topic ; Gene Expression ; Hematologic Neoplasms/diagnosis ; Hematologic Neoplasms/mortality ; Humans ; Isoenzymes/antagonists & inhibitors ; Isoenzymes/genetics ; Mice ; Protein Serine-Threonine Kinases/genetics ; Proto-Oncogene Proteins/genetics ; Survival Analysis ; Tumor Cells, Cultured ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Polo-Like Kinase 1